Xencor (XNCR) Current Assets (2013 - 2026)
Xencor (XNCR) reported Current Assets of $482.9 million for Q1 2026, down 7.37% year-over-year from $521.3 million in Q1 2025, and down 19.5% quarter-over-quarter from $599.8 million in Q4 2025.
Xencor (XNCR) Current Assets (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Current Assets data on file, last reported at $482.9 million in Q1 2026.
- Current Assets for Q1 2026 came in at $482.9 million, down 7.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $482.9 million (down 7.37% YoY), and the FY2025 annual result was $599.8 million, up 3.85% from the prior year.
- Current Assets eased to $482.9 million in Q1 2026 per XNCR's latest filing, from $599.8 million in the prior quarter.
- Over five years, Current Assets peaked at $675.3 million in Q4 2022 and troughed at $482.9 million in Q1 2026.
- A 5-year average of $577.2 million and a median of $577.6 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets jumped 102.65% in 2022, then fell 14.49% in 2023.
- A 5-year view of Current Assets shows it stood at $675.3 million in 2022, then dropped by 5.88% to $635.6 million in 2023, then dropped by 9.13% to $577.6 million in 2024, then increased by 3.85% to $599.8 million in 2025, then fell by 19.5% to $482.9 million in 2026.
- Business Quant data shows XNCR's Current Assets at $482.9 million in Q1 2026, $599.8 million in Q4 2025, and $518.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 482.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 482.86 Mn |
| Dec 31, 2025 | 599.82 Mn |
| Sep 30, 2025 | 518.44 Mn |
| Jun 30, 2025 | 513.15 Mn |
| Mar 31, 2025 | 521.27 Mn |
| Dec 31, 2024 | 577.60 Mn |
| Sep 30, 2024 | 589.60 Mn |
| Jun 30, 2024 | 568.92 Mn |
| Mar 31, 2024 | 574.85 Mn |
| Dec 31, 2023 | 635.60 Mn |
| Sep 30, 2023 | 571.18 Mn |
| Jun 30, 2023 | 593.56 Mn |
| Mar 31, 2023 | 629.98 Mn |
| Dec 31, 2022 | 675.34 Mn |
| Sep 30, 2022 | 668.00 Mn |
| Jun 30, 2022 | 585.94 Mn |
| Mar 31, 2022 | 505.97 Mn |
| Dec 31, 2021 | 424.37 Mn |
| Sep 30, 2021 | 329.63 Mn |
| Jun 30, 2021 | 480.97 Mn |